1-3 of 3
Naveen Subramanian
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Attrition after Referral for Chimeric Antigen Receptor T-Cell (CAR-T) Products in Multiple Myeloma (MM)

Naveen Subramanian, Ashwath Gurumurthi, Oren Pasvolsky, Christopher Ferreri, Hans C. Lee, Elisabet E. Manasanch, Sheeba K. Thomas, Donna M. Weber, Mahmoud Gaballa, Christen Dillard, Melody Becnel, Chitra Hosing, Pei Lin, Behrang Amini, Muzaffar H. Qazilbash, Nilesh Kalariya, Misha Hawkins, Sairah Ahmed, Robert Z. Orlowski, Krina K. Patel
Journal: Blood
Blood (2023) 142 (Supplement 1): 3794.
https://doi.org/10.1182/blood-2023-187583
Published: 2023
Journal Articles

Safety and Efficacy Outcomes for Patients with High-Risk Multiple Myeloma Receiving Idecabtagene Vicleucel: The MD Anderson Experience

Oren Pasvolsky, Michelle Hildebrandt, Naveen Subramanian, Christopher Ferreri, Hans C. Lee, Elisabet E. Manasanch, Sheeba K. Thomas, Donna M. Weber, Mahmoud Gaballa, Christen Dillard, Melody Becnel, Chitra Hosing, Pei Lin, Behrang Amini, Muzaffar H. Qazilbash, Nilesh Kalariya, Robert Z. Orlowski, Krina K. Patel
Journal: Blood
Blood (2023) 142 (Supplement 1): 4712.
https://doi.org/10.1182/blood-2023-187854
Published: 2023
Journal Articles

Clinical Factors Associated with Catheter-Related VTE in Patients Undergoing Hematopoietic Cell Transplantation

Naveen Subramanian, Katherine Klein, Danielle Guffey, Partow Kebriaei, Gabriela Rondon, Elizabeth J. Shpall, Jeff Jin, Elliana Young, Ang Li, Cristhiam M. Rojas Hernandez
Journal: Blood
Blood (2023) 142 (Supplement 1): 2359.
https://doi.org/10.1182/blood-2023-182490
Published: 2023